Evaluation of exercise performance, cardiac function, and quality of life in children after liver transplantation

Transplantation

Volumn 100, Issue 7, 2016, Pages 1525-1531

  Vandekerckhove, Kristof ^a   Coomans, Ilse ^a   De Bruyne, Elke ^b   De Groote, Katya ^a   Panzer, Joseph ^a   De Wolf, Daniel ^a   Boone, Jan ^b   De Bruyne, Ruth ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ANAEROBIC THRESHOLD; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; DIASTOLE; DIASTOLIC DYSFUNCTION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ECHOCARDIOGRAPHY; EMOTION; EXERCISE; FEMALE; FITNESS; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE WALL; HUMAN; INTERVENTRICULAR SEPTUM; LIVER TRANSPLANTATION; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL ASPECT; SYSTOLE; ADOLESCENT; BODY MASS; EXERCISE TEST; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; LIVER FAILURE; POSTOPERATIVE PERIOD; PSYCHOLOGY; TIME FACTOR;

ADOLESCENT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; OXYGEN CONSUMPTION; PHYSICAL FITNESS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84961641005     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001167     Document Type: Article

References (35)

1. Kamath BM, Olthoff KM. Liver transplantation in children: update 2010. Pediatr Clin North Am. 2010;57:401-414.
2. Lavie CJ, Arena R, Swift DL, et al. Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res. 2015;117: 207-219.
3. Albeldawi M, Aggarwal A, Madhwal S, et al. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl. 2012;18: 370-375.
4. Ortega FB, Ruiz JR, CastilloMJ, et al. Physical fitness in childhood and adolescence: A powerful marker of health. Int J Obes (Lond). 2008;32:1-11.
5. Unnithan VB, Veehof SH, Rosenthal P, et al. Fitness testing of pediatric liver transplant recipients. Liver Transpl. 2001;7:206-212.
6. Maria da Silva R, Brunow de CarvalhoW, Johnston C, et al. Functional capacity after pediatric liver transplantation: A pilot study. Pediatr Transplant. 2014;18:586-593.
7. Tomczak CR, Warburton DE, Riess KJ, et al. Pulmonary oxygen uptake and heart rate kinetics during the six-minute walk test in transplant recipients. Transplantation. 2008;85:29-35.
8. American Thoracic Society, American College of Chest Physicians. ATS/ ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
9. Stephenson AL, Yoshida EM, Abboud RT, et al. Impaired exercise performance after successful liver transplantation. Transplantation. 2001;72: 1161-1164.
10. Krasnoff JB, Mathias R, Rosenthal P, et al. The comprehensive assessment of physical fitness in children following kidney and liver transplantation. Transplantation. 2006;82:211-217.
11. Sanchez C, Eymann A, De Cunto C, et al. Quality of life in pediatric liver transplantation in a single-center in South America. Pediatr Transplant. 2010;14:332-336.
12. Alonso EM, Limbers CA, Neighbors K, et al. Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients. J Pediatr. 2010;156:270-276.
13. Weissberg-Benchell J, Zielinski TE, Rodgers S, et al. Pediatric healthrelated quality of life: feasibility, reliability and validity of the PedsQL transplant module. Am J Transplant. 2010;10:1677-1685.
14. Wasserman K. Principles of Exercise Testing and Interpretation. Lippincott Williams & Wilkins; 2012.
15. BeaverWL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986;60:2020-2027.
16. Myers J, Walsh D, Buchanan N, et al. Can maximal cardiopulmonary capacity be recognized by a plateau in oxygen uptake Chest. 1989;96: 1312-1316.
17. Milani RV, Lavie CJ, Mehra MR, et al. Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc. 2006;81:1603-1611.
18. Armstrong N, Welsman JR. Assessment and interpretation of aerobic fitness in children and adolescents. Exerc Sport Sci Rev. 1994;22:435-476.
19. Pettersen MD, Du W, Skeens ME, et al. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: An echocardiographic study. J Am Soc Echocardiogr. 2008;21:922-934.
20. Varni JW, Seid M, Kurtin PS. PedsQL 4. 0: reliability and validity of the Pediatric Quality of Life Inventory version 4. 0 generic core scales in healthy and patient populations. Med Care. 2001;39:800-812.
21. Vanhees L, Lefevre J, Philippaerts R, et al. How to assess physical activity How to assess physical fitness Eur J Cardiovasc Prev Rehabil. 2005;12:102-114.
22. Prentis JM, Manas DMD, Trenell MI, et al. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl. 2012;18:152-159.
23. Hudnall SD. Cardiac hypertrophy postliver transplantation: A role for FK506 and cyclosporine A Transplantation. 2002;74:757-758.
24. Norozi K, Gravenhorst V, Hobbiebrunken E, et al. Normality of cardiopulmonary capacity in children operated on to correct congenital heart defects. Arch Pediatr Adolesc Med. 2005;159:1063-1068.
25. Shimiaie J, Sherez J, Aviram G, et al. Determinants of effort intolerance in patients with heart failure: combined echocardiography and cardiopulmonary stress protocol. JACC Heart Fail. 2015;3:803-814.
26. Myers J, Ashley E. Dangerous curves. A perspective on exercise, lactate, and the anaerobic threshold. Chest. 1997;111:787-795.
27. Fussner LA, Heimbach JK, Fan C, et al. Cardiovascular disease after liver transplantation: when, what, and who is at risk. Liver Transpl. 2015;21: 889-896.
28. Chang RK, McDiarmid SV, Alejos JC, et al. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation. Pediatr Transplant. 2001;5:187-191.
29. Nakata Y, Yoshibayashi M, Yonemura T, et al. Tacrolimus and myocardial hypertrophy. Transplantation. 2000;69:1960-1962.
30. Raevens S, De Pauw M, Geerts A, et al. Prevalence and outcome of diastolic dysfunction in liver transplantation recipients. Acta Cardiol. 2014;69: 273-280.
31. Baskar S, George PL, Eghtesad B, et al. Cardiovascular risk factors and cardiac disorders in long-term survivors of pediatric liver transplantation. Pediatr Transplant. 2015;19:48-55.
32. Shalev A, Nir A, Granot E. Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage. Pediatr Transplant. 2005;9:718-722.
33. Derakhshan A, Derakhshan D, Amoozgar H, et al. Exercise test in pediatric renal transplant recipients and its relationship with their cardiac function. Pediatr Transplant. 2014;18:246-253.
34. Varni JW, Limbers CA, Sorensen LG, et al. PedsQL™Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity. Qual Life Res. 2011;20:913-921.
35. Kosola S, Lampela H, Lauronen J, et al. General health, health-related quality of life and sexual health after pediatric liver transplantation: A nationwide study. Am J Transplant. 2012;12:420-427.